Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

NCT05028231 · clinicaltrials.gov ↗

UNKNOWN

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Neoadjuvant Therapies

Interventions

PROCEDURE: Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy

Sponsor

Tongji Hospital

Collaborators

[object Object]